Patrick Christmas II | Senior Vice President and General Counsel |
Ken Mills | President and Chief Executive Officer |
Stephen Yoo | Senior Vice President and Chief Medical Officer |
Vit Vasista | Senior Vice President and Chief Financial Officer |
Gena Wang | Barclays |
Vikram Purohit | Morgan Stanley |
Gbola Amusa | Chardan Capital |
Ying Huang | Bank of America Merrill Lynch |
Reni Benjamin | Raymond James |
Good day, ladies and gentlemen, and welcome to the third quarter 2018 REGENXBIO earnings conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions].
As a reminder, this conference may be recorded.